Actinogen Medical Ltd
ASX:ACW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Actinogen Medical Ltd
ASX:ACW
|
AU |
|
S
|
Standard Chartered PLC
SWB:STD
|
UK |
|
A
|
Aditya Infotech Ltd
NSE:CPPLUS
|
IN |
|
Strattec Security Corp
NASDAQ:STRT
|
US |
|
M
|
Mas P.l.c
JSE:MSP
|
MT |
|
China Construction Bank Corp
OTC:CICHF
|
CN |
Intrinsic Value
Is ACW undervalued or overvalued?
See the intrinsic value estimate for Actinogen Medical Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ACW looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ACW’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Actinogen Medical Does
Actinogen Medical Ltd is a clinical-stage biotechnology company focused on drugs for brain diseases. Its main program is Xanamem, a tablet medicine designed to reduce excess cortisol activity in the brain, which the company is studying for conditions such as Alzheimer’s disease and other cognitive disorders. In simple terms, it is trying to turn a science idea into a prescription treatment for memory and thinking problems.
- Headquarters
- Australia AU
- IPO date
- Oct 16, 2007
Earnings Waterfall
Actinogen Medical Ltd
The intrinsic value for Actinogen Medical Ltd (ACW) under the Base Case is hidden AUD.
Compared with the current market price of 0.0465 AUD, the stock appears hidden.